Comparative study of brachytherapy using ring and ovoid applicators in treatment of advanced cervical cancer

BackgroundImage-guided brachytherapy became essential to cervical cancer treatment following chemo-radiotherapy. A variety of applicators including Tandem-Ring (TR) and Tandem-Ovoid (TO) applicators are used to apply brachytherapy.ObjectiveThis study aims to dosimetrically compare TR versus TO applicators by using two different optimization techniques.MethodsBoth applicator sets were applied to the 24 patients. The prescribed dose was 7 Gy/fraction, and the treatment plans were normalized to HR-CTV. Two different optimization techniques are applied, along the four treatment fractions. The first optimization technique was a theoretical assumption that aimed to deliver 7 Gy to 90 % of the volume of the HR-CTV. While the second was the clinical situation which aimed to preserve the organs at risk (OARs) according to the ICRU 89 dose-volume constraints, considering that, 90% of HR-CTV is covered by not less than 90% of the prescribed dose. DVHs were generated, and dosimetric parameters including point A, and D2cc of rectum, bladder, and sigmoid, as well as the dose at different volumes of HR-CTV and IR-CTV, were recorded and compared.ResultsThe results demonstrate that using Ovoid-Tandem applicators achieved significantly higher dose at point A, significantly higher coverage to both HR-CTV and IR-CTV, in addition to significantly better protection to the mean D2cc of the rectum in both optimization techniques. On the other hand, using Ring-Tandem applicators give significantly more protection to the mean D2cc of the bladder, but HR-CTV and IR-CTV have significantly lower coverage.ConclusionOvoid-Tandem and Ring-Tandem applicators are the most common interchangeable intracavitary gynecological applicators. In this study, the results demonstrated that Ovoid-Tandem applicators have the advantages of significantly higher coverage for HR-CTV, and IR-CTV, in addition to more protection for D2cc of the rectum. On the contrary, Ring-Tandem applicators can provide higher protection for D2cc of the bladder, and more comfort to the patients.

Authors

Institutions

Publication Details

Journal
International Journal of Risk & Safety in Medicine
Published
2025-06-19
DOI
https://doi.org/10.1177/09246479251353380
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative study of brachytherapy using ring and ovoid applicators in treatment of advanced cervical cancer

Reham S Sherif, Reem H. El-Gebaly, Mohamed Shehata, Reham A. Abdel Aziz et al.
International Journal of Risk & Safety in Medicine
Endometrial and Cervical Cancer Treatments
article

Comparative study of brachytherapy using ring and ovoid applicators in treatment of advanced cervical cancer

Reham S Sherif, Reem H. El-Gebaly, Mohamed Shehata, Reham A. Abdel Aziz, Hend M Kareem
article en

Abstract

BackgroundImage-guided brachytherapy became essential to cervical cancer treatment following chemo-radiotherapy. A variety of applicators including Tandem-Ring (TR) and Tandem-Ovoid (TO) applicators are used to apply brachytherapy.ObjectiveThis study aims to dosimetrically compare TR versus TO applicators by using two different optimization techniques.MethodsBoth applicator sets were applied to the 24 patients. The prescribed dose was 7 Gy/fraction, and the treatment plans were normalized to HR-CTV. Two different optimization techniques are applied, along the four treatment fractions. The first optimization technique was a theoretical assumption that aimed to deliver 7 Gy to 90 % of the volume of the HR-CTV. While the second was the clinical situation which aimed to preserve the organs at risk (OARs) according to the ICRU 89 dose-volume constraints, considering that, 90% of HR-CTV is covered by not less than 90% of the prescribed dose. DVHs were generated, and dosimetric parameters including point A, and D2cc of rectum, bladder, and sigmoid, as well as the dose at different volumes of HR-CTV and IR-CTV, were recorded and compared.ResultsThe results demonstrate that using Ovoid-Tandem applicators achieved significantly higher dose at point A, significantly higher coverage to both HR-CTV and IR-CTV, in addition to significantly better protection to the mean D2cc of the rectum in both optimization techniques. On the other hand, using Ring-Tandem applicators give significantly more protection to the mean D2cc of the bladder, but HR-CTV and IR-CTV have significantly lower coverage.ConclusionOvoid-Tandem and Ring-Tandem applicators are the most common interchangeable intracavitary gynecological applicators. In this study, the results demonstrated that Ovoid-Tandem applicators have the advantages of significantly higher coverage for HR-CTV, and IR-CTV, in addition to more protection for D2cc of the rectum. On the contrary, Ring-Tandem applicators can provide higher protection for D2cc of the bladder, and more comfort to the patients.

International Journal of Risk & Safety in MedicineVol. 36(4)
Cairo University (EG), Menoufia University (EG)
Good health and well-being
Openalex Percentile: Top 81%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.